LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -25.0% | 10,930 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 10,930 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -72.0% | 10,930 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | -50.0% | 10,930 | 0.0% | 0.00% | – |
| Q3 2021 | $50,000 | +2.0% | 10,930 | 0.0% | 0.00% | – |
| Q2 2021 | $49,000 | -87.6% | 10,930 | -79.8% | 0.00% | – |
| Q1 2021 | $394,000 | -7.7% | 53,998 | -3.3% | 0.00% | – |
| Q4 2020 | $427,000 | +61.1% | 55,827 | +91.2% | 0.00% | – |
| Q3 2020 | $265,000 | +8.2% | 29,194 | +0.8% | 0.00% | – |
| Q2 2020 | $245,000 | +137.9% | 28,955 | +38.9% | 0.00% | – |
| Q1 2020 | $103,000 | -31.8% | 20,852 | 0.0% | 0.00% | – |
| Q4 2019 | $151,000 | -32.9% | 20,852 | 0.0% | 0.00% | – |
| Q3 2019 | $225,000 | -23.7% | 20,852 | -8.3% | 0.00% | – |
| Q2 2019 | $295,000 | +30.0% | 22,739 | -1.0% | 0.00% | – |
| Q1 2019 | $227,000 | – | 22,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,220,000 | 0.38% |
| Orbimed Advisors | 8,466,783 | $37,593,000 | 0.38% |
| Sio Capital Management, LLC | 182,630 | $811,000 | 0.20% |
| Tibra Equities Europe Ltd | 76,500 | $340,000 | 0.10% |
| SAMLYN CAPITAL, LLC | 1,420,452 | $6,308,000 | 0.09% |
| PURA VIDA INVESTMENTS, LLC | 249,256 | $1,107,000 | 0.03% |
| Trexquant Investment LP | 46,229 | $205,000 | 0.02% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $67,000 | 0.01% |
| Baker Brothers Advisors | 451,478 | $2,005,000 | 0.01% |
| Verition Fund Management LLC | 208,099 | $924,000 | 0.01% |